The company “Pharmak” plans for 3 years to increase exports to the Russian Federation in half. The relevant data contained in the report of the company prepared for shareholders and creditors, reports “Capital” with slyly on “Ukrainian news”.
As follows from the document, Russia is the fastest growing sales market for Ukrainian pharmaceutical company. In 2017, Farmak has increased the export of drugs by 31%. In monetary terms growth in exports last year amounted to more than $ 70 million. According to the results of 2017 in the structure of foreign sales dominated Poland, Uzbekistan and Russia. In particular, exports to Poland amounted to 28.3% of total exports of JSC “Farmak”, in Uzbekistan — of 20.9% in Russia and 16.7%.
“The company predicts growth in exports of 33% in the current year compared to the previous. The growth of overseas shipments in 2018 is expected due to the increase in exports to the Russian Federation. The weight of this country in the structure of exports of JSC “Farmak” will be 18.6%, an increase of almost 2 percentage points compared with the 2017 year and 7 percentage points, or one and a half times, compared with the year 2016. Share of Poland will shrink by 2.8% to 25.5% compared to the previous year, and 7.8% compared to last year. According to the Unified state register of legal entities, individuals-entrepreneurs and public formations of the Ministry of justice in the capital of Russia Moscow operates a representative office of PJSC “Farmak”. On the official website of the company indicates that the number of staff of the Russian representative office is 76 people,” writes Capital.